Slides on Pediatric Psoriasis: Informed Decisions That Improve Clinical Outcomes

See how to involve families and young patients in care, and review the effective treatments
person default
Jim Treat, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 247 KB
Released: December 21, 2020

Acknowledgements

Provided by Clinical Care Options

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

This activity is supported by an educational grant from
Lilly

For further information concerning Lilly grant funding visit www.lillygrantoffice.com

Related Content

CCO slides on when to use interleukins inhibitors in psoriatis arthritis: biologic dmard or MTX naive? IL-17A secukinumab, ixekizumab; IL-12/23 ustekinumab.

Vinod Chandran, MBBS, MD, DM, PhD person default Alexis Ogdie, MD, MSCE Released: December 29, 2020

CME for CCO on when to use interleukin inhibitors in psoriatis arthritis: biologic DMARD or MTX naive? IL-17A secukinumab, ixekizumab; IL-12/23 ustekinumab

Vinod Chandran, MBBS, MD, DM, PhD person default Alexis Ogdie, MD, MSCE Physicians: maximum of 0.5 AMA PRA Category 1 Credits Released: December 29, 2020 Expired: December 28, 2021

Hear from expert Jim Treat, MD, on optimizing care of pediatric patients with plaque psoriasis, including systemic options, working with families, and more

person default Jim Treat, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 21, 2020 Expired: December 20, 2021

New from EULAR 2020, Clinical Care Options (CCO): adults with immune-mediated inflammatory disease report biologic-associated fatigue in Dutch Biologic Monitor

Released: August 13, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue